BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 24, 2019
View Archived Issues
More microbes between heaven and earth
Read More
Ammonia scavenger prevents tox at the source
Read More
Dormancy, resistance are separate issues in metastasis prevention
Read More
Funding supports further phase I development of Minervax's group B Streptococcus vaccine
Read More
HIF-2alpha inhibitor reverses pulmonary vascular remodeling, inhibits RHF, promotes survival in PAH
Read More
Novel selective tankyrase inhibitor blocks proliferation of colorectal cancer cells in rodent models
Read More
KZR-616, a dual immunoproteasome subunit inhibitor for autoimmune diseases
Read More
Bermekimab demonstrates efficacy in confirmatory study in patients with hidradenitis suppurativa
Read More
First patient enrolled in phase II study of SGM-1019 for the treatment of NASH
Read More
Athersys announces positive results from exploratory study of MultiStem cell therapy in ARDS
Read More
PeptiDream announces new BBB-penetrating PDC discovery deal with Shionogi
Read More
Phase IIb study of centanafadine sustained release in adults with ADHD meets primary endpoint
Read More
Phase II data presented for andecaliximab plus nivolumab in gastric cancer
Read More
Genentech and NewLink Genetics patent IDO and TDO inhibitors
Read More
Durvalumab and tremelimumab plus chemotherapy show promising safety in patients with ESCC
Read More
Medshine Discovery synthesizes new IRAK-4 inhibitors
Read More
[18F]RO-948 PET differentiates Alzheimer's disease from other neurodegenerative conditions
Read More
NantBioScience discloses new BACE1 inhibitors
Read More
The Vanderbilt University identifies metabotropic mGlu4 receptor PAMs
Read More
Sarepta initiates open-label extension study of SRP-5051 in Duchenne muscular dystrophy
Read More
Recordati Industria Chimica e Farmaceutica divulges mGlu5 receptor PAMs
Read More
CAMP4 Therapeutics announces rare disease research collaboration with Alnylam
Read More
New phase II trial explores use of huCART19 in very high-risk subsets of pediatric B-ALL
Read More
Basilea and Roche will collaborate to study derazantinib with atezolizumab in urothelial cancer
Read More
Ironwood begins first-in-human study of CNS-penetrant sGC stimulator IW-6463
Read More
FDA places partial clinical hold on phase III study of axalimogene filolisbac in cervical cancer
Read More